Curriculum Vitae
At a Glance
| Title | Dr. rer. nat. |
| Name | Hannah Sabeth Schwarzer-Sperber |
| Current Position | Group Leader / Principal Investigator |
| Institution | Institute for the Research on HIV & AIDS-associated Diseases, University Medicine Essen (UME), Essen, Germany |
| hannah.schwarzer-sperber@uk-essen.de | |
| ORCID | 0000-0002-9638-6555 |
| h-index | 5 (Web of Science, Aug 2025) |
Professional Experience
| Jan 2024 – present Essen, Germany |
Principal Investigator
|
| Mar 2021 – Dec 2023 Essen, Germany |
Postdoctoral Fellow
|
| Jun 2017 – Mar 2021 San Francisco, CA |
Doctoral Researcher
|
| Feb 2017 – May 2021 San Francisco, CA |
Research Assistant
|
| Aug 2016 – Feb 2017 Berlin, Germany |
Self‑employed Image Analyst
|
| Sep 2014 – May 2016 Rehovot, Israel |
Master’s Student
|
| Nov 2013 – Sep 2014 Berlin, Germany |
Research Student
|
| Feb 2013 – Nov 2013 Berlin, Germany |
Bachelor Student
|
| Oct 2010 – Dec 2013 Berlin, Germany |
Tutor
|
Education & Degrees
| Jun 2017 – Sep 2021 Berlin, Germany |
Dr. rer. nat., Biochemistry
|
| Oct 2013 – Sep 2016 Berlin, Germany |
Master of Molecular Life Sciences
|
| Oct 2009 – Nov 2013 Berlin, Germany |
Bachelor of Biology
|
Contributions to Science
My research integrates mechanistic studies of viral persistence, discovery of broad-spectrum antivirals, dissection of viral entry pathways, advanced imaging, and systems-level profiling to drive translational virology.
HIV Latency & Reactivation
Defining how cellular pathways—hypoxia, glucocorticoid signaling, and AKT/mTOR—regulate latent HIV reservoirs, and evaluating in vivo and ex vivo strategies for latency reversal.
- The hypoxia‑regulated ectonucleotidase CD73 is a host determinant of HIV latency. Cell Reports (2023)
- Reactivation of latent HIV‑1 by the glucocorticoid receptor modulator AZD9567. Journal of Virology (2025)
- μ‑Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies. FASEB Journal (2020)
Antiviral Discovery & Virus Entry Inhibition
Development of repurposed and novel small molecules, and characterization of endogenous proteins, to block coronavirus entry and replication.
- Identification of nsp16 inhibitors of SARS‑CoV‑2, SARS‑CoV‑1 and MERS‑CoV from FDA‑approved drugs. Biomedicine & Pharmacotherapy (2025)
- Diketopiperazine/piperidine alkaloid as a potential broad‑spectrum coronaviral entry inhibitor. Biomedicine & Pharmacotherapy (2025)
- The bovine seminal plasma protein PDC‑109 possesses pan‑antiviral activity. Viruses (2022)
Viral Entry Mechanisms & Advanced Imaging
Utilizing high‑resolution microscopy and flow cytometry to dissect entry pathways of hantaviruses and visualize dynamic host–virus interactions.
- Macropinocytosis and clathrin‑dependent endocytosis play pivotal roles for the infectious entry of Puumala virus. Journal of Virology (2020)
- Advances in fluorescence microscopy for orthohantavirus research. Microscopy (2023)
- Characterization of hantavirus N protein intracellular dynamics and localization. Viruses (2022)
Systems Biology & Transcriptomic Profiling
Applying large‑scale transcriptomic and computational approaches to reveal molecular networks in human tissues and model organisms.